• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Heart Failure Study Links Epicardial Fat Mapping to Ejection Fraction Recovery

by
November 14, 2026
in Health
Reading Time: 7 mins read
0
Heart Failure Study Links Epicardial Fat Mapping to Ejection Fraction Recovery

Heart Failure Study Links Epicardial Fat Mapping to Ejection Fraction Recovery

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A single-center retrospective exploratory study of 119 patients with heart failure with reduced ejection fraction at The First Affiliated Hospital of Ningbo University found that the statistical relationship between magnetic resonance relaxation measurements of epicardial adipose tissue and subsequent improvement in left ventricular ejection fraction differed depending on patient body mass index. Publishing in Frontiers in Cardiovascular Medicine, investigators reported that an interaction term between body mass index category and standardized continuous native T1 of epicardial adipose tissue yielded an odds ratio of 0.396 in their primary multivariable model. However, the researchers emphasized that the study was exploratory and hypothesis-generating, as subgroup estimates within specific weight categories were statistically imprecise, several sensitivity models showed fluctuating statistical strength, and the tissue-level meaning of the imaging signal remains incompletely defined in human clinical imaging.

Heart failure with reduced ejection fraction exhibits substantial variability in whether patients experience left ventricular functional recovery following guideline-directed pharmacological therapies or device interventions. While body mass index is widely measured in routine cardiovascular care as an index of overall body size, it cannot differentiate adipose tissue from lean muscle mass, fails to reflect regional fat distribution, and in patients with heart failure may be confounded by systemic fluid retention and congestion. Although prior investigations linked lower epicardial fat volume and elevated computed tomography attenuation to left ventricular improvement, and human proteomic studies documented inflammatory and metabolic pathway alterations in cardiac adipose deposits, the relationship between local magnetic resonance tissue relaxation properties and functional recovery across varying body habitus remained unaddressed.

The research team reviewed a previously established cardiovascular magnetic resonance database at the First Affiliated Hospital of Ningbo University, screening 142 individuals with baseline magnetic resonance imaging, clinical assessments, and subsequent echocardiographic follow-up. After excluding 23 patients whose baseline magnetic resonance left ventricular ejection fraction was at or above 40 percent, the final analytic cohort comprised 119 adult patients with clinically diagnosed heart failure with reduced ejection fraction and baseline magnetic resonance ejection fraction under 40 percent imaged between April 2021 and November 2025. Using standard Chinese adult weight criteria, participants were categorized by a body mass index cutoff of 24 kilograms per square meter, yielding 52 patients below this threshold and 67 patients at or above it. Overall, the median age was 53 years in the lower body mass index group and 51 years in the higher group, with 34 of 52 and 56 of 67 patients being male, reflecting an overall cohort with only 29 female participants.

Patients in the higher body mass index category presented with significantly higher prevalences of hypertension at 50.7 percent compared to 28.8 percent, and diabetes mellitus at 31.3 percent compared to 11.5 percent, alongside higher median left ventricular end-diastolic diameter of 62.5 millimeters versus 57.0 millimeters and higher glycated hemoglobin of 6.0 percent versus 5.8 percent. Conversely, atrial fibrillation was more prevalent among patients with a body mass index under 24, affecting 26.9 percent compared to 10.4 percent in the higher category. Documented heart failure etiologies were comparable between groups, with 37 classified as ischemic, 64 as non-ischemic, and 18 remaining unclassified. Discharge medical therapy was well balanced, with beta-blockers prescribed to over 94 percent of patients in both groups and renin-angiotensin inhibitors or receptor-neprilysin inhibitors prescribed to roughly 90 percent. Guideline-directed medical therapy intensification occurred during follow-up in approximately 30 percent of patients in each group, while no revascularization or rhythm procedures occurred.

Cardiovascular magnetic resonance examinations were conducted using a clinical 3.0-Tesla scanner platform, utilizing standard cine imaging for ventricular structural metrics alongside a modified Look-Locker inversion recovery sequence across 11 cardiac cycles to obtain native T1 mapping at basal, mid-ventricular, and apical short-axis positions. Epicardial adipose tissue volume was quantified offline by manually tracing contours on end-diastolic short-axis cine slices from the mitral annulus to the apex, excluding intracavitary blood, myocardium, coronary vessels, pericardial fluid, and extracardiac depots, then indexed to body surface area to yield the epicardial adipose tissue volume index. Patients with higher body mass index exhibited greater median fat volume index at 29.42 milliliters per square meter compared to 21.51 milliliters per square meter in the lower group. However, patient-level representative regional native T1 was significantly lower in the higher weight group, displaying a median of 371.71 milliseconds versus 388.49 milliseconds, with no significant monotonic correlation between fat volume index and native T1 across the cohort.

Native T1 values were derived from regions of interest placed manually within epicardial fat on one to three valid short-axis slices per patient, deliberately positioned away from the myocardial boundary, visceral pericardium, and coronary vessels to minimize partial-volume contamination. Across 302 included slices, median region area was 0.338 square centimeters, with overall patient values computed as area-weighted averages. An independent retrospective review confirmed that 80.5 percent of regions displayed satisfactory image quality, while 10.3 percent exhibited artifacts and 9.3 percent had indistinct boundaries, though artifacts did not disrupt within-region measurements. Interobserver reproducibility tested in 20 randomly selected patients revealed an intraclass correlation coefficient of 0.895 for patient-level native T1 without proportional bias. However, slice-level reproducibility across 55 matched slices demonstrated a lower intraclass correlation of 0.826 and significant proportional bias, indicating that slice selection and contour placement introduce notable technical variability.

Longitudinal functional recovery was evaluated using clinically documented transthoracic echocardiography, defining left ventricular ejection fraction improvement operationally as an absolute increase of at least 10 percentage points between baseline and the final eligible examination performed within a 3-to-18-month follow-up window. Median actual follow-up duration was 6.13 months across the cohort, and the median interval between baseline cardiovascular magnetic resonance and baseline echocardiography was two days, being 14 days or fewer in 116 patients. Overall, 53 of the 119 participants achieved this improvement threshold, representing 44.5 percent of the cohort. Ejection fraction improvement occurred in 16 of 52 patients with a body mass index under 24 kilograms per square meter, corresponding to 30.8 percent, compared to 37 of 67 patients with a body mass index of 24 or greater, representing 55.2 percent, a difference that reached statistical significance with a p-value of 0.009.

To test whether the prognostic relationship between epicardial fat relaxation times and functional improvement differed by weight status, researchers constructed a multivariable logistic regression model including body mass index category, standardized full-cohort continuous native T1 z-score, and their interaction term. The primary specification adjusted for patient age, sex, baseline echocardiographic ejection fraction, epicardial adipose volume index, and the calendar interval between baseline magnetic resonance and echocardiography. The interaction odds ratio was 0.396 with a 95 percent confidence interval of 0.161 to 0.975 and a Wald p-value of 0.044, with likelihood ratio testing confirming improved model fit. When deriving category-specific estimates from this interaction model, each one-standard-deviation increase in epicardial fat native T1 corresponded to an odds ratio of 1.407 among patients with body mass index under 24, compared to an odds ratio of 0.557 among those with body mass index of 24 or greater. Crucially, neither subgroup estimate achieved statistical significance, as both confidence intervals encompassed unity.

For purely descriptive presentation, the investigators stratified patients into four categories based on the cohort median epicardial fat native T1 of 378.98 milliseconds combined with the binary body mass index cutoff. Among participants with body mass index under 24, ejection fraction improvement occurred in 40.6 percent of those with high native T1 compared to 15.0 percent of those with low native T1. Among participants with body mass index of 24 or higher, improvement occurred in 42.9 percent of those with high native T1 versus 64.1 percent of those with low native T1. The authors explicitly cautioned that these joint categories served only to illustrate the observed interaction pattern descriptively, stressing that the within-cohort median cannot be interpreted as a clinically validated diagnostic cutoff, a biological threshold, or a tool for patient risk stratification.

The investigators conducted extensive sensitivity and influence analyses to assess the stability of the observed interaction. Firth bias-corrected logistic regression yielded an interaction odds ratio of 0.435, and restricting the analysis to 96 patients with baseline echocardiographic ejection fraction strictly below 40 percent produced an odds ratio of 0.354. However, statistical significance at the nominal 0.05 level was lost when adjusting for follow-up duration, applying a natural cubic spline to baseline ejection fraction, adjusting for total region-of-interest area, restricting follow-up to an approximately six-month window, or analyzing absolute ejection fraction change as a continuous linear variable. Additional sensitivity models excluding six patients with cardiac resynchronization therapy or jointly adjusting for atrial fibrillation and renal function yielded interaction point estimates near 0.40, but their 95 percent confidence intervals crossed 1.0, highlighting substantial uncertainty.

To address potential outcome misclassification arising from routine clinical echocardiography reports, a certified echocardiographer blinded to baseline magnetic resonance data, tissue relaxation times, and original report classifications independently remeasured paired examinations in 117 patients. Paired remeasurement agreed with original clinical improvement classifications in 113 of 117 cases, representing 96.6 percent concordance, with only four patients reclassified across the threshold. When re-estimating the multivariable models, using paired remeasured baseline and follow-up ejection fractions yielded an interaction odds ratio of 0.383 with a 95 percent confidence interval of 0.156 to 0.942. Bland-Altman comparisons between remeasured and clinical-report values demonstrated minimal mean differences of negative 0.17 percentage points at baseline and 0.10 percentage points at follow-up, indicating high categorical consistency while acknowledging that echocardiographic measurement errors and modality discrepancies cannot be entirely eliminated.

The study authors emphasized multiple methodological and clinical limitations that constrain interpretation of their findings. The single-center retrospective design, modest sample size of 119 individuals, and occurrence of 53 outcome events limited statistical power and precision, precluding definitive conclusions. Body mass index remains a crude surrogate for adiposity in heart failure that cannot differentiate fat from muscle mass or account for subclinical congestion, and direct measures of body composition such as waist circumference were unrecorded. Furthermore, clinical modified Look-Locker T1 mapping sequences lack established histological specificity in human epicardial fat, meaning elevated native T1 cannot be assumed to represent tissue inflammation, interstitial fibrosis, or edema. The authors concluded that their observations must be regarded as exploratory and hypothesis-generating, requiring independent prospective multicenter validation with comprehensive body composition assessments and standardized imaging protocols before clinical utility can be contemplated.

Subject of Research: Cardiovascular magnetic resonance assessment of epicardial adipose tissue native T1 relaxation times and echocardiographic left ventricular ejection fraction improvement across body mass index categories in heart failure with reduced ejection fraction

Article Title: Epicardial adipose tissue native T1 and LVEF improvement across BMI categories in HFrEF: an exploratory CMR study

Article References: Guo, H., Huang, J., Yu, Q., Xie, J., Du, W., Song, Y., Li, C., Chen, X., & Su, J. (2026). Epicardial adipose tissue native T1 and LVEF improvement across BMI categories in HFrEF: an exploratory CMR study. Frontiers in Cardiovascular Medicine, 13, Article 1949156. https://doi.org/10.3389/fcvm.2026.1949156

Image Credits: AI Generated

DOI: 10.3389/fcvm.2026.1949156

Keywords: cardiovascular magnetic resonance, epicardial adipose tissue, heart failure with reduced ejection fraction, native T1 mapping, left ventricular ejection fraction, body mass index, echocardiographic recovery, myocardial reverse remodeling, modified Look-Locker inversion recovery, cardiac imaging, tissue characterization, prognostic interaction, Firth logistic regression, interobserver reproducibility, adipose tissue relaxation, clinical cardiology, observational imaging study

News Source: Ophelia Keating. (November 14, 2026). Heart Failure Study Links Epicardial Fat Mapping to Ejection Fraction Recovery. Scienmag.

Tags: adipose tissue relaxationbody-mass indexcardiac imagingcardiovascular magnetic resonanceClinical cardiologyechocardiographic recoveryepicardial adipose tissueFirth logistic regressionHeart Failure with Reduced Ejection Fractioninterobserver reproducibilityleft ventricular ejection fractionmodified Look-Locker inversion recoverymyocardial reverse remodelingnative T1 mappingobservational imaging studyprognostic interactionTissue characterization
Share12Tweet7Share2ShareShareShare1

Related Posts

Delayed Fatal Coronary Event Follows Multiple Bee Stings in Probable Kounis Syndrome

Delayed Fatal Coronary Event Follows Multiple Bee Stings in Probable Kounis Syndrome

November 20, 2026
Blood Ratio Combining Clotting and Kidney Markers Tracks Gout Severity

Blood Ratio Combining Clotting and Kidney Markers Tracks Gout Severity

November 20, 2026

Physical Activity Not Linked to Colon Cancer Tumor Immune Infiltration

November 20, 2026

Cisplatin and Capecitabine Chemoradiation Shows Feasibility in Localized Anal Canal Cancer

November 20, 2026

POPULAR NEWS

  • Gene Knockouts and Buffer Systems Boost Bacillus subtilis Spore Display Yields

    Gene Knockouts and Buffer Systems Boost Bacillus subtilis Spore Display Yields

    29 shares
    Share 12 Tweet 7
  • Narrative Review Integrates Imaging, Biomechanics, and Movement in Lumbar Spondylolysis

    29 shares
    Share 12 Tweet 7
  • Bifrontal Brain Stimulation Improves Working Memory in Schizophrenia Without Sex Differences

    29 shares
    Share 12 Tweet 7
  • Robotic and Conventional Knee Replacements Show Comparable One-Year Joint Infection Rates

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Researchers Extend Positive Geometries to Branch Cuts and String Scattering Amplitudes

Delayed Fatal Coronary Event Follows Multiple Bee Stings in Probable Kounis Syndrome

Blood Ratio Combining Clotting and Kidney Markers Tracks Gout Severity

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.